New Drug Stops Pediatric Cancer

SAN FRANCISCO. (Ivanhoe Newswire) – DIPG is the second most common brain tumor in kids. The diagnosis is tough to deliver. It is almost always the same—little boys and girls are given less than two years to live. In fact, the median survival rate is only nine months and so far, there are no good treatment options. But doctors hope one family’s sacrifice will change all of that!
Source: Medical Headlines From Ivanhoe.com - Category: Consumer Health News Source Type: news